Opportunities and obstacles for deep learning in biology and medicine

Travers Ching(University of Hawaiʻi at Mānoa), Daniel Himmelstein(Translational Therapeutics (United States)), Brett K. Beaulieu‐Jones(University of Pennsylvania), Alexandr A. Kalinin(University of Michigan), T. Brian(Harvard University), Gregory P. Way(Translational Therapeutics (United States)), Enrico Ferrero(GlaxoSmithKline (United Kingdom)), Paul‐Michael Agapow(Imperial College London), Michael Zietz(Translational Therapeutics (United States)), Michael M. Hoffman(University of Toronto), Wei Xie(Vanderbilt University), Gail Rosen(Drexel University), Benjamin J. Lengerich(Carnegie Mellon University), Johnny Israeli(Stanford University), Jack Lanchantin(University of Virginia), Stephen Woloszynek(Drexel University), Anne E. Carpenter(Broad Institute), Avanti Shrikumar(Stanford University), Jinbo Xu(Toyota Technological Institute at Chicago), Evan M. Cofer(Princeton University), Christopher A. Lavender(National Institutes of Health), Srinivas C. Turaga(Howard Hughes Medical Institute), Amr M. Alexandari(Stanford University), Zhiyong Lu(National Institutes of Health), David J. Harris(University of Florida), David DeCaprio, Yanjun Qi(University of Virginia), Anshul Kundaje(Stanford University), Yifan Peng(National Institutes of Health), Laura K. Wiley(University of Colorado Denver), Marwin Segler(University of Münster), Simina M. Boca(Georgetown University), S. Joshua Swamidass(Washington University in St. Louis), Austin Huang(Brown University), Anthony Gitter(University of Wisconsin–Madison), Casey S. Greene(Translational Therapeutics (United States))
Journal of The Royal Society Interface
April 1, 2018
Cited by 2,221Open Access
Full Text

Abstract

Deep learning describes a class of machine learning algorithms that are capable of combining raw inputs into layers of intermediate features. These algorithms have recently shown impressive results across a variety of domains. Biology and medicine are data-rich disciplines, but the data are complex and often ill-understood. Hence, deep learning techniques may be particularly well suited to solve problems of these fields. We examine applications of deep learning to a variety of biomedical problems-patient classification, fundamental biological processes and treatment of patients-and discuss whether deep learning will be able to transform these tasks or if the biomedical sphere poses unique challenges. Following from an extensive literature review, we find that deep learning has yet to revolutionize biomedicine or definitively resolve any of the most pressing challenges in the field, but promising advances have been made on the prior state of the art. Even though improvements over previous baselines have been modest in general, the recent progress indicates that deep learning methods will provide valuable means for speeding up or aiding human investigation. Though progress has been made linking a specific neural network's prediction to input features, understanding how users should interpret these models to make testable hypotheses about the system under study remains an open challenge. Furthermore, the limited amount of labelled data for training presents problems in some domains, as do legal and privacy constraints on work with sensitive health records. Nonetheless, we foresee deep learning enabling changes at both bench and bedside with the potential to transform several areas of biology and medicine.


Related Papers

No related papers found

Powered by citation graph analysis